SRT1720通过损害自流来抑制膀癌细胞的进展

Lanlan Li1, Shengjun Fu1, Jianliang Wang2

  • 1Institute of Urology, Key Laboratory of Urological Disease in Gansu Province, Clinical Research Center for Urology in Gansu Province, Lanzhou University Second Hospital, No. 82 Cuiyingmen, Lanzhou 730030, Gansu, China.

PubMed
概括

SRT1720通过诱导亡和阻断自流来抑制膀癌的生长. 这种化合物显示出作为治疗膀癌治疗的新治疗策略的前景,准关键的细胞过程.